Skeletal myoblasts for cardiac repair

Papers of special note have been highlighted as: of interest ▪▪ of considerable interest

Bibliography

• 1  Cleland JG, McGowan J: Heart failure due to ischaemic heart disease: epidemiology, pathophysiology and progression. J. Cardiovasc. Pharmacol.33(Suppl. 3),S17–S29 (1999).
  Medline CASGoogle Scholar
• 2  Frangogiannis NG: The immune system and cardiac repair. Pharmacol. Res.58,88–111 (2008).
  Medline CASGoogle Scholar
• 3  Haqqani HM, Mond HG: The implantable cardioverter-defibrillator lead: principles, progress, and promises. Pacing Clin. Electrophysiol.32,1336–1353 (2009).
  MedlineGoogle Scholar
• 4  Alba AC, Delgado DH: The future is here: ventricular assist devices for the failing heart. Expert Rev. Cardiovasc. Ther.7,1067–1077 (2009).
  MedlineGoogle Scholar
• 5  Soonpaa MH, Field LJ: Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am. J. Physiol.272,H220–H226 (1997).
  Medline CASGoogle Scholar
• 6  Rubart M, Field LJ: Cardiac regeneration: repopulating the heart. Annu. Rev. Physiol.68,29–49 (2006).▪ Critical review of heart cell therapy.
  Medline CASGoogle Scholar
• 7  Bergmann O, Bhardwaj RD, Bernard S et al.: Evidence for cardiomyocyte renewal in humans. Science324,98–102 (2009).▪▪ Excellent study demonstrating cardiomyocyte renewal in the postnatal heart.
  Medline CASGoogle Scholar
• 8  Hassink RJ, Pasumarthi KB, Nakajima H et al.: Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc. Res.78,18–25 (2008).
  Medline CASGoogle Scholar
• 9  Anversa P, Leri A, Kajstura J, Nadal-Ginard B: Myocyte growth and cardiac repair. J. Mol. Cell Cardiol.34,91–105 (2002).▪ Discusses the potential of cardiomyocytes to replicate in the postnatal heart.
  Medline CASGoogle Scholar
• 10  Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res.92,139–150 (2003).
  Medline CASGoogle Scholar
• 11  Anversa P, Kajstura J, Leri A, Bolli R: Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation113,1451–1463 (2006).▪ Discusses the inherent capacity of the mammalian heart for self-renewal.
  MedlineGoogle Scholar
• 12  Beltrami AP, Barlucchi L, Torella D et al.: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell114,763–776 (2003).
  Medline CASGoogle Scholar
• 13  Anversa P, Leri A, Kajstura J: Cardiac regeneration. J. Am. Coll. Cardiol.47,1769–1776 (2006).
  MedlineGoogle Scholar
• 14  Bearzi C, Leri A, Lo Monaco F et al.: Identification of a coronary vascular progenitor cell in the human heart. Proc. Natl Acad. Sci. USA106(37),15885–15890 (2009).
  Medline CASGoogle Scholar
• 15  Rota M, Padin-Iruegas ME, Misao Y et al.: Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ. Res.103,107–116 (2008).
  Medline CASGoogle Scholar
• 16  Dawn B, Stein AB, Urbanek K et al.: Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl Acad. Sci. USA102,3766–3771 (2005).
  Medline CASGoogle Scholar
• 17  Matsuura K, Honda A, Nagai T et al.: Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J. Clin. Invest.119,2204–2217 (2009).
  Medline CASGoogle Scholar
• 18  Leri A, Hosoda T, Rota M, Kajstura J, Anversa P: Myocardial regeneration by exogenous and endogenous progenitor cells. Drug Discov. Today Dis. Mech.4,197–203 (2007).
  MedlineGoogle Scholar
• 19  Kajstura J, Rota M, Whang B et al.: Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res.96,127–137 (2005).
  Medline CASGoogle Scholar
• 20  Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P: Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. NY Acad. Sci.938,221–229 (2001).
  Medline CASGoogle Scholar
• 21  Kudo M, Wang Y, Wani MA et al.: Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J. Mol. Cell Cardiol.35,1113–1119 (2003).▪ Provides evidence that bone marrow stem cells differentiate to adopt cardiac phenotype.
  Medline CASGoogle Scholar
• 22  Haider H, Ye L, Jiang S et al.: Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J. Mol. Med.82,539–549 (2004).▪▪ Large animal study showing the effectiveness of skeletal myoblast (SM)-based angiogenic gene therapy of the infarcted heart.
  MedlineGoogle Scholar
• 23  Nelson TJ, Martinez-Fernandez A, Yamada S et al.: Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation120,408–416 (2009).
  MedlineGoogle Scholar
• 24  Siu CW, Moore JC, Li RA: Human embryonic stem cell-derived cardiomyocytes for heart therapies. Cardiovasc. Hematol. Disord. Drug Targets7,145–152 (2007).
  Medline CASGoogle Scholar
• 25  Crisostomo PR, Abarbanell AM, Wang M et al.: Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. Am. J. Physiol. Heart Circ. Physiol.295,H1726–H1735 (2008).
  Medline CASGoogle Scholar
• 26  Martinez-Fernandez A, Nelson TJ, Yamada S et al.: iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ. Res.105,648–656 (2009).
  Medline CASGoogle Scholar
• 27  Halbach M, Pfannkuche K, Pillekamp F et al.: Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation. Circ. Res.101,484–492 (2007).
  Medline CASGoogle Scholar
• 28  Ye L, Haider H, Jiang S et al.: Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model. Eur. J. Heart Fail.7,945–952 (2005).▪ Small animal cryoinjury model to show cardiac reparability of SMs.
  MedlineGoogle Scholar
• 29  Menasche P, Alfieri O, Janssens S et al.: The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation117,1189–1200 (2008).▪▪ First randomized, placebo-controlled study using SMs in humans.
  MedlineGoogle Scholar
• 30  Ye L, Haider H, Tan R et al.: Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair. Biomaterials29,2125–2137 (2008).▪ Nonviral angiogenic gene modification of SMs for myocardial repair.
  Medline CASGoogle Scholar
• 31  Ye L, Haider H, Tan R et al.: Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation116,I113–I120 (2007).
  Medline CASGoogle Scholar
• 32  Khan M, Kutala VK, Vikram DS et al.: Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. Am. J. Physiol. Heart Circ. Physiol.293,H2129–H2139 (2007).
  Medline CASGoogle Scholar
• 33  Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126,663–676 (2006).
  Medline CASGoogle Scholar
• 34  Yamanaka S: Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell21,39–49 (2007).▪ Summary of the role of transcription factors and chromatin remodeling during reprogramming.
  Google Scholar
• 35  Freund C, Mummery CL: Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J. Cell Biochem.107,592–599 (2009).
  Medline CASGoogle Scholar
• 36  Mauritz C, Schwanke K, Reppel M et al.: Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation118,507–517 (2008).
  MedlineGoogle Scholar
• 37  Mias C, Lairez O, Trouche E et al.: Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells27(11),2734–2743 (2009).
  Medline CASGoogle Scholar
• 38  Schuleri KH, Feigenbaum GS, Centola M et al.: Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur. Heart J.30(22),2722–2732 (2009).
  MedlineGoogle Scholar
• 39  Hoashi T, Matsumiya G, Miyagawa S et al.: Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. J. Thorac. Cardiovasc. Surg.138,460–467 (2009).
  MedlineGoogle Scholar
• 40  Ghostine S, Carrion C, Souza LC et al.: Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation106,I131–I136 (2002).▪ Long-term effectiveness of SM therapy.
  MedlineGoogle Scholar
• 41  Gavira JJ, Herreros J, Perez A et al.: Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J. Thorac. Cardiovasc. Surg.131,799–804 (2006).
  MedlineGoogle Scholar
• 42  Ince H, Petzsch M, Rehders TC et al.: Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J. Endovasc. Ther.11,695–704 (2004).
  MedlineGoogle Scholar
• 43  Menasche P: Skeletal myoblasts as a therapeutic agent. Prog. Cardiovasc. Dis.50,7–17 (2007).
  MedlineGoogle Scholar
• 44  Haider H, Tan AC, Aziz S, Chachques JC, Sim EK: Myoblast transplantation for cardiac repair: a clinical perspective. Mol. Ther.9,14–23 (2004).▪ Review of the clinical studies involving SM transplantation.
  Medline CASGoogle Scholar
• 45  Al Attar N, Carrion C, Ghostine S et al.: Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc. Res.58,142–148 (2003).
  Medline CASGoogle Scholar
• 46  Taylor DA, Atkins BZ, Hungspreugs P et al.: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med.4,929–933 (1998).
  Medline CASGoogle Scholar
• 47  McCue JD, Swingen C, Feldberg T et al.: The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. J. Heart Lung Transplant27,116–123 (2008).
  MedlineGoogle Scholar
• 48  Brasselet C, Morichetti MC, Messas E et al.: Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. Eur. Heart J.26,1551–1556 (2005).
  MedlineGoogle Scholar
• 49  Hata H, Matsumiya G, Miyagawa S et al.: Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J. Thorac. Cardiovasc. Surg.132,918–924 (2006).
  MedlineGoogle Scholar
• 50  He KL, Yi GH, Sherman W et al.: Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J. Heart Lung Transplant.24,1940–1949 (2005).
  MedlineGoogle Scholar
• 51  Ye L, Haider H, Jiang S et al.: Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1. Eur. J. Heart Fail.9,15–22 (2007).
  Medline CASGoogle Scholar
• 52  Chazaud B, Hittinger L, Sonnet C et al.: Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage. Cardiovasc. Res.58,444–450 (2003).
  Medline CASGoogle Scholar
• 53  Zhang Z, van den Bos EJ, Wielopolski PA et al.: High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner. MAGMA17,201–209 (2004).
  Medline CASGoogle Scholar
• 54  Atkins BZ, Hueman MT, Meuchel J et al.: Cellular cardiomyoplasty improves diastolic properties of injured heart. J. Surg. Res.85,234–242 (1999).
  Medline CASGoogle Scholar
• 55  Marelli D, Desrosiers C, el-Alfy M, Kao RL, Chiu RC: Cell transplantation for myocardial repair: an experimental approach. Cell Transplant.1,383–390 (1992).
  Medline CASGoogle Scholar
• 56  Reinecke H, Murry CE: Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc. Pathol.9,337–344 (2000).
  Medline CASGoogle Scholar
• 57  Murry CE, Wiseman RW, Schwartz SM, Hauschka SD: Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest.98,2512–2523 (1996).
  Medline CASGoogle Scholar
• 58  Reinecke H, MacDonald GH, Hauschka SD, Murry CE: Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J. Cell Biol.149,731–740 (2000).
  Medline CASGoogle Scholar
• 59  Peterson JM, Pizza FX: Cytokines derived from cultured skeletal muscle cells after mechanical strain promote neutrophil chemotaxis in vitro. J. Appl. Physiol.106,130–137 (2009).
  Medline CASGoogle Scholar
• 60  Tatsumi R, Hattori A, Ikeuchi Y, Anderson JE, Allen RE: Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol. Biol. Cell13,2909–2918 (2002).
  Medline CASGoogle Scholar
• 61  Pouzet B, Ghostine S, Vilquin JT et al.: Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation104,I223–I228 (2001).▪ Small animal study supporting clinical relevance of SM therapy for myocardial repair.
  Medline CASGoogle Scholar
• 62  Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M: Ex vivo delivered stromal cell-derived factor-1α promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J. Mol. Cell Cardiol.42,792–803 (2007).
  Medline CASGoogle Scholar
• 63  Murtuza B, Suzuki K, Bou-Gharios G et al.: Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc. Natl Acad. Sci. USA101,4216–4221 (2004).
  Medline CASGoogle Scholar
• 64  Suzuki K, Murtuza B, Smolenski RT et al.: Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation104,I207–I212 (2001).▪ SM-based angiomyogenic repair of the heart.
  Medline CASGoogle Scholar
• 65  Aharinejad S, Abraham D, Paulus P et al.: Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc. Res.79,395–404 (2008).
  Medline CASGoogle Scholar
• 66  Toh R, Kawashima S, Kawai M et al.: Transplantation of cardiotrophin-1-expressing myoblasts to the left ventricular wall alleviates the transition from compensatory hypertrophy to congestive heart failure in Dahl salt-sensitive hypertensive rats. J. Am. Coll. Cardiol.43,2337–2347 (2004).
  Medline CASGoogle Scholar
• 67  Formigli L, Francini F, Nistri S et al.: Skeletal myoblasts overexpressing relaxin improve differentiation and communication of primary murine cardiomyocyte cell cultures. J. Mol. Cell. Cardiol.47,335–345 (2009).
  Medline CASGoogle Scholar
• 68  Bonacchi M, Nistri S, Nanni C et al.: Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy. J. Cell Mol. Med.13,3437–3448 (2009).
  MedlineGoogle Scholar
• 69  Kim CK, Haider KH, Lim SJ: Gene medicine: a new field of molecular medicine. Arch Pharm Res.24,1–15 (2001).
  Medline CASGoogle Scholar
• 70  Ye L, Haider HK, Esa WB et al.: Liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischemic limb disease. J. Cell Mol. Med.14(1–2),323–336 (2010).
  Medline CASGoogle Scholar
• 71  Chanseaume S, Azarnoush K, Maurel A et al.: Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium? Interact. Cardiovasc. Thorac. Surg.6,293–297 (2007).
  MedlineGoogle Scholar
• 72  Lafreniere JF, Mills P, Tremblay JP, El Fahime E: Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity. Transplantation77,1741–1747 (2004).
  Medline CASGoogle Scholar
• 73  Kim HW, Haider HK, Jiang S, Ashraf M: Ischemic preconditioning augments survival of stem cells via MIR-210 expression by targeting caspase-8 associated protein 2. J. Biol. Chem.284(48),33161–33168 (2009).▪▪ First study to extrapolate the concept of ischemic preconditioning to promote donor cell survival with a mechanistic participation of miRNA-210.
  MedlineGoogle Scholar
• 74  Niagara MI, Haider H, Jiang S, Ashraf M: Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ. Res.100,545–555 (2007).▪ First study to use preconditioning mimetic diazoxide to enhance SM survival in the infarcted heart.
  Medline CASGoogle Scholar
• 75  Ott HC, Kroess R, Bonaros N et al.: Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation. Eur. J. Cardiothorac. Surg.27,1017–1021 (2005).
  MedlineGoogle Scholar
• 76  Menasche P, Hagege AA, Scorsin M et al.: Myoblast transplantation for heart failure. Lancet357,279–280 (2001).▪▪ First-in-man use of SMs for cardiac repair.
  Medline CASGoogle Scholar
• 77  Hagege AA, Carrion C, Menasche P et al.: Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet361,491–492 (2003).▪▪ First direct evidence from human heart that transplanted SMs differentiated into myofibers in the infarcted heart.
  MedlineGoogle Scholar
• 78  Menasche P, Hagege AA, Vilquin JT et al.: Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol.41,1078–1083 (2003).
  MedlineGoogle Scholar
• 79  Pagani FD, DerSimonian H, Zawadzka A et al.: Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol.41,879–888 (2003).▪ First human study involving SM transplantation as an adjunct to left ventricle assist device implantation.
  MedlineGoogle Scholar
• 80  Dib N, McCarthy P, Campbell A et al.: Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant.14,11–19 (2005).
  MedlineGoogle Scholar
• 81  Herreros J, Prosper F, Perez A et al.: Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J.24,2012–2020 (2003).
  MedlineGoogle Scholar
• 82  Siminiak T, Kalawski R, Fiszer D et al.: Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am. Heart J.148,531–537 (2004).
  MedlineGoogle Scholar
• 83  Dib N, Campbell A, Jacoby DB et al.: Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium. J. Pharmacol. Toxicol. Methods54,71–77 (2006).
  Medline CASGoogle Scholar
• 84  Siminiak T, Fiszer D, Jerzykowska O et al.: Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur. Heart J.26,1188–1195 (2005).
  MedlineGoogle Scholar
• 85  Dib N, Dinsmore J, Lababidi Z et al.: One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc. Interv.2,9–16 (2009).
  MedlineGoogle Scholar
• 86  Larose E, Proulx G, Voisine P et al.: Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study. Catheter. Cardiovasc. Interv.75,120–127 (2010).
  MedlineGoogle Scholar
• 87  Smits PC, van Geuns RJ, Poldermans D et al.: Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol.42,2063–2069 (2003).
  MedlineGoogle Scholar
• 88  Chachques JC, Herreros J, Trainini J et al.: Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int. J. Cardiol.95(Suppl. 1),S29–S33 (2004).▪ First study demonstrating the advantage of using autologous serum to support SM culture.
  MedlineGoogle Scholar
• 89  Ferreira-Cornwell MC, Luo Y, Narula N, Lenox JM, Lieberman M, Radice GL: Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J. Cell Sci.115,1623–1634 (2002).
  Medline CASGoogle Scholar
• 90  Formigli L, Francini F, Tani A et al.: Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell–cell contacts and relaxin treatment. Am. J. Physiol. Cell Physiol.288,C795–C804 (2008).
  Google Scholar
• 91  Suzuki K, Brand NJ, Allen S et al.: Overexpression of connexin 43 in skeletal myoblasts: relevance to cell transplantation to the heart. J. Thorac. Cardiovasc. Surg.122,759–766 (2001).
  Medline CASGoogle Scholar
• 92  Roell W, Lewalter T, Sasse P et al.: Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature450,819–824 (2007).
  Medline CASGoogle Scholar
• 93  Fernandes S, van Rijen HV, Forest V et al.: Cardiac cell therapy: overexpression of connexin 43 in skeletal myoblasts and prevention of ventricular arrhythmias. J. Cell Mol. Med.13(9B),3703–3712 (2009).
  MedlineGoogle Scholar
• 94  Garcia J, Tanabe T, Beam KG: Relationship of calcium transients to calcium currents and charge movements in myotubes expressing skeletal and cardiac dihydropyridine receptors. J. Gen. Physiol.103,125–147 (1994).
  Medline CASGoogle Scholar
• 95  Abraham MR, Hare JM: Is skeletal myoblast transplantation proarrhythmic? The jury is still out. Heart Rhythm3,462–463 (2006).
  MedlineGoogle Scholar
• 96  Fouts K, Fernandes B, Mal N, Liu J, Laurita KR: Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm3,452–461 (2006).▪▪ Electrophysiological consequences of SM transplantation.
  MedlineGoogle Scholar
• 97  Eisen HJ: Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med.5,520–521 (2008).
  MedlineGoogle Scholar
• 98  Suzuki K, Murtuza B, Beauchamp JR et al.: Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J.18,1153–1155 (2004).
  Medline CASGoogle Scholar
• 99  Haider H, Ashraf M: Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J. Mol. Cell Cardiol.45,554–566 (2008).▪ Review of various preconditioning approaches to promote stem cell survival.
  Medline CASGoogle Scholar
• 100  Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M: Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc. Res.77,134–142 (2008).
  Medline CASGoogle Scholar
• 101  El Fahime E, Bouchentouf M, Benabdallah BF et al.: Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success. Biochem. Cell Biol.81,81–90 (2003).
  Medline CASGoogle Scholar
• 102  Jiang S, Kh Haider H, Ahmed RP, Idris NM, Salim A, Ashraf M: Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium. J. Mol. Cell Cardiol.44,582–596 (2008).
  Medline CASGoogle Scholar
• 103  Kan CD, Li SH, Weisel RD, Zhang S, Li RK: Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation. J. Am. Coll. Cardiol.50,1086–1092 (2007).
  MedlineGoogle Scholar
• 104  Haider H, Jiang SJ, Ye L, Aziz S, Law PK, Sim EK: Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair. Transplant Proc.36,232–235 (2004).▪▪ First study to show the immunoprivileged status of SMs after transplantation into the infarcted myocardium.
  Medline CASGoogle Scholar
• 105  Law PK, Fang G, Chua F, Kakuchaya T, Bockeria LA: First-in-man myoblast allografts for heart degeneration. Int. J. Med. Implants Devices1,100–155 (2003).
  Google Scholar
• 106  Conboy IM, Conboy MJ, Smythe GM, Rando TA: Notch-mediated restoration of regenerative potential to aged muscle. Science302,1575–1577 (2003).
  Medline CASGoogle Scholar
• 107  Chen JF, Mandel EM, Thomson JM et al.: The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet.38,228–233 (2006).
  Medline CASGoogle Scholar
• 108  Foshay KM, Gallicano GI: Small RNAs, big potential: the role of microRNAs in stem cell function. Curr. Stem Cell Res. Ther.2,264–271 (2007).
  Medline CASGoogle Scholar
• 109  Hime GR, Somers WG: Micro-RNA mediated regulation of proliferation, self-renewal and differentiation of mammalian stem cells. Cell Adh. Migr.3(4),425–432 (2009).
  MedlineGoogle Scholar
• 110  Callis TE, Chen JF, Wang DZ: MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol.26,219–225 (2007).
  Medline CASGoogle Scholar
• 111  Chen JF, Callis TE, Wang DZ: MicroRNAs and muscle disorders. J. Cell Sci.122,13–20 (2009).
  Medline CASGoogle Scholar
• 112  Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A: Muscle-specific microRNA miR-206 promotes muscle differentiation. J. Cell Biol.174,677–687 (2006).
  Medline CASGoogle Scholar
• 113  Anderson C, Catoe H, Werner R: MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res.34,5863–5871 (2006).
  Medline CASGoogle Scholar
• 114  Pouzet B, Vilquin JT, Hagege AA et al.: Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized? Circulation102,III210–III215 (2000).
  Medline CASGoogle Scholar
• 115  Fukushima S, Coppen SR, Lee J et al.: Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS ONE3,e3071 (2008).▪ Demonstrates the effect of route of administration on the outcome of SM-based therapy.
  MedlineGoogle Scholar
• 116  Skuk D, Goulet M, Tremblay JP: Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant.15,659–663 (2006).
  MedlineGoogle Scholar
• 117  Suzuki K, Murtuza B, Fukushima S et al.: Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation110,II225–II230 (2004).
  MedlineGoogle Scholar
• 118  Suzuki K, Brand NJ, Smolenski RT, Jayakumar J, Murtuza B, Yacoub MH: Development of a novel method for cell transplantation through the coronary artery. Circulation102,III359–III364 (2000).
  Medline CASGoogle Scholar
• 119  Perin EC, Dohmann HF, Borojevic R et al.: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation107,2294–2302 (2003).
  MedlineGoogle Scholar
• 120  Gavira JJ, Perez-Ilzarbe M, Abizanda G et al.: A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Cardiovasc. Res.71,744–753 (2006).
  Medline CASGoogle Scholar
• 121  Gavira JJ, Nasarre E, Abizanda G et al.: Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. Eur. Heart J.31(8),1013–1021 (2009).
  MedlineGoogle Scholar
• 122  Premaratne GU, Tambara K, Fujita M et al.: Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ. J.70,1184–1189 (2006).
  MedlineGoogle Scholar
• 123  Martens TP, Godier AF, Parks JJ et al.: Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant.18,297–304 (2009).
  MedlineGoogle Scholar
• 124  Hamdi H, Furuta A, Bellamy V et al.: Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann. Thorac. Surg.87,1196–1203 (2009).
  MedlineGoogle Scholar
• 125  Giraud MN, Ayuni E, Cook S, Siepe M, Carrel TP, Tevaearai HT: Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction. Artif. Organs32,692–700 (2008).
  Medline CASGoogle Scholar
• 126  Sherman W, He KL, Yi GH et al.: Myoblast transfer in ischemic heart failure: effects on rhythm stability. Cell Transplant.18,333–341 (2009).
  MedlineGoogle Scholar
• 127  Ye L, Haider H, Sim EK: Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells. Exp. Biol. Med. (Maywood)231,8–19 (2006).
  Medline CASGoogle Scholar
• 128  Lafreniere JF, Caron MC, Skuk D, Goulet M, Cheikh AR, Tremblay JP: Growth factor co-injection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplant.18(7),719–730 (2009).
  MedlineGoogle Scholar
• 129  Mikhail Konoplyannikov M, Jiang S, Ahmed R, Ashraf M, Haider HK: Reversal of ischemic cardiomyopathy using reprogrammed skeletal myoblasts overexpressing multiple therapeutic growth factor genes. Circulation120,S773–S774 (2009).
  Google Scholar
• 130  Beauchamp JR, Morgan JE, Pagel CN, Partridge TA: Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol.144,1113–1122 (1999).▪ Demonstrates the dynamics of SM transplantation.
  Medline CASGoogle Scholar
• 131  Winitsky SO, Gopal TV, Hassanzadeh S et al.: Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol.3,e87 (2005).
  MedlineGoogle Scholar
• 132  Okada M, Payne TR, Zheng B et al.: Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J. Am. Coll. Cardiol.52,1869–1880 (2008).
  MedlineGoogle Scholar
• 133  Sim EK, Haider HK, Aziz S, Ooi OC, Law PK: Myoblast transplantation on the beating heart. Int. Surg.90,148–150 (2005).
  MedlineGoogle Scholar
• 134  Biagini E, Valgimigli M, Smits PC et al.: Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure. Eur. J. Heart Fail.8,641–648 (2006).
  MedlineGoogle Scholar